Proteo-peptidomic profiling of biofluids is used to identify disease biomarkers and to study molecular mechanisms of pathology development. Previously, we studied changes in cerebrospinal fluid (CSF) and blood plasma associated with Guillain-Barre syndrome (GBS)—a rare and severe disorder of the peripheral nervous system with an unknown etiology. Here, we describe the workflow for the analysis of endogenous peptides from CSF. The procedure covers sample preparation, liquid chromatography-mass spectrometry (LC-MS) analysis, and bioinformatics analysis and allows identification of more than 1100 peptides from 181 protein groups in ~3 h from a single CSF sample derived from non-neurological, non-oncological patients.
CITATION STYLE
Ziganshin, R. H., Kovalchuk, S. I., & Azarkin, I. V. (2019). Peptidomic workflow applied to cerebrospinal fluid analysis. In Methods in Molecular Biology (Vol. 2044, pp. 111–118). Humana Press Inc. https://doi.org/10.1007/978-1-4939-9706-0_7
Mendeley helps you to discover research relevant for your work.